Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Installs Genentech's Bohen To Head Late Development

This article was originally published in Scrip

Executive Summary

Immersed in a wide-ranging R&D overhaul, AstraZeneca PLC has moved quickly to fill a key gap in its senior management team by appointing Sean Bohen its new executive vice president of global medicines development and chief medical officer, replacing Briggs Morrison who vacated the post in June to join a biotech.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC029576

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel